tiprankstipranks
pc:orbis

Orbis Medicines

Copenhagen, DK
https://www.orbismedicines.com/
Orbis Medicines is focused on the development of next-generation oral macrocycle drugs, utilizing its proprietary nGen platform. The platform leverages automated chemistry and machine learning to systematically design oral macrocycles, initially targeting validated blockbuster biologic targets.

Leadership & Board

Current Number of Employees47
Current LinkedIn Followers5,093

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$90M
Total Amount Raised$90M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$90M
Latest Funding Amount$90M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Orbis Medicines had 47 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
47Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Orbis Medicines had 5,093 followers as of April 6, 2026. The number of followers increased by 28 (0.55%) week-over-week.
5,093Latest Followers Count
28(0.55%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$90.00M

Investors

Related News and Analysis